Literature DB >> 24165130

Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.

Sho Amatsu1, Yo Sugawara, Takuhiro Matsumura, Kengo Kitadokoro, Yukako Fujinaga.   

Abstract

Clostridium botulinum HA is a component of the large botulinum neurotoxin complex and is critical for its oral toxicity. HA plays multiple roles in toxin penetration in the gastrointestinal tract, including protection from the digestive environment, binding to the intestinal mucosal surface, and disruption of the epithelial barrier. At least two properties of HA contribute to these roles: the sugar-binding activity and the barrier-disrupting activity that depends on E-cadherin binding of HA. HA consists of three different proteins, HA1, HA2, and HA3, whose structures have been partially solved and are made up mainly of β-strands. Here, we demonstrate structural and functional reconstitution of whole HA and present the complete structure of HA of serotype B determined by x-ray crystallography at 3.5 Å resolution. This structure reveals whole HA to be a huge triskelion-shaped molecule. Our results suggest that whole HA is functionally and structurally separable into two parts: HA1, involved in recognition of cell-surface carbohydrates, and HA2-HA3, involved in paracellular barrier disruption by E-cadherin binding.

Entities:  

Keywords:  Bacterial Pathogenesis; Bacterial Toxins; Botulinum Toxin; Carbohydrate-binding Protein; Crystal Structure; E-cadherin; Epithelial Cell; Hemagglutinin; Protein Complexes

Mesh:

Substances:

Year:  2013        PMID: 24165130      PMCID: PMC3853306          DOI: 10.1074/jbc.M113.521179

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes.

Authors:  Y Fujinaga; K Inoue; T Nomura; J Sasaki; J C Marvaud; M R Popoff; S Kozaki; K Oguma
Journal:  FEBS Lett       Date:  2000-02-11       Impact factor: 4.124

2.  In vitro reconstitution of the Clostridium botulinum type D progenitor toxin.

Authors:  Hirokazu Kouguchi; Toshihiro Watanabe; Yoshimasa Sagane; Hiroyuki Sunagawa; Tohru Ohyama
Journal:  J Biol Chem       Date:  2001-11-16       Impact factor: 5.157

3.  Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia.

Authors:  Hideyuki Arimitsu; Kaoru Inoue; Yoshihiko Sakaguchi; Jaechul Lee; Yukako Fujinaga; Toshihiro Watanabe; Tohru Ohyama; Robert Hirst; Keiji Oguma
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

4.  The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells.

Authors:  Atsushi Nishikawa; Nobuo Uotsu; Hideyuki Arimitsu; Jae-Chul Lee; Yutaka Miura; Yukako Fujinaga; Hiroshi Nakada; Toshihiro Watanabe; Tohru Ohyama; Yoshiyuki Sakano; Keiji Oguma
Journal:  Biochem Biophys Res Commun       Date:  2004-06-25       Impact factor: 3.575

5.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

6.  Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum.

Authors:  Kaoru Inoue; Mack Sobhany; Thomas R Transue; Keiji Oguma; Lars C Pedersen; Masahiko Negishi
Journal:  Microbiology       Date:  2003-12       Impact factor: 2.777

7.  Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes.

Authors:  Yukako Fujinaga; Kaoru Inoue; Shinobu Watarai; Yoshihiko Sakaguchi; Hideyuki Arimitsu; Jae-Chul Lee; Yingji Jin; Takuhiro Matsumura; Yuko Kabumoto; Toshihiro Watanabe; Tohru Ohyama; Atsushi Nishikawa; Keiji Oguma
Journal:  Microbiology       Date:  2004-05       Impact factor: 2.777

8.  Structure of the integrin alpha2beta1-binding collagen peptide.

Authors:  Jonas Emsley; C Graham Knight; Richard W Farndale; Michael J Barnes
Journal:  J Mol Biol       Date:  2004-01-23       Impact factor: 5.469

Review 9.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

10.  Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.

Authors:  N Sonoda; M Furuse; H Sasaki; S Yonemura; J Katahira; Y Horiguchi; S Tsukita
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

View more
  20 in total

1.  Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna-Magdalena Kruel; Stefan Mahrhold; Kay Perry; Luisa W Cheng; Andreas Rummel; Rongsheng Jin
Journal:  Toxicon       Date:  2015-08-10       Impact factor: 3.033

2.  Reversible Association of the Hemagglutinin Subcomplex, HA-33/HA-17 Trimer, with the Botulinum Toxin Complex.

Authors:  Yoshimasa Sagane; Shingo Mutoh; Ryosuke Koizumi; Tomonori Suzuki; Shin-Ichiro Miyashita; Keita Miyata; Tohru Ohyama; Koichi Niwa; Toshihiro Watanabe
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

Review 3.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

4.  High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna Magdalena Kruel; Kay Perry; Andreas Rummel; Rongsheng Jin
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

5.  Purification, crystallization and preliminary X-ray analysis of an HA17-HA70 (HA2-HA3) complex from Clostridium botulinum type C progenitor toxin.

Authors:  Chikako Iwasa; Takashi Tonozuka; Masaya Shinoda; Yoshimasa Sagane; Koichi Niwa; Toshihiro Watanabe; Hiromi Yoshida; Shigehiro Kamitori; Toshifumi Takao; Keiji Oguma; Atsushi Nishikawa
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

6.  The hypothetical protein P47 of Clostridium botulinum E1 strain Beluga has a structural topology similar to bactericidal/permeability-increasing protein.

Authors:  Kwok-Ho Lam; Ruifeng Qi; Shun Liu; Amelie Kroh; Guorui Yao; Kay Perry; Andreas Rummel; Rongsheng Jin
Journal:  Toxicon       Date:  2017-10-16       Impact factor: 3.033

Review 7.  Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery.

Authors:  Kwok-Ho Lam; Rongsheng Jin
Journal:  Curr Opin Struct Biol       Date:  2015-04-15       Impact factor: 6.809

8.  Structural basis of the pH-dependent assembly of a botulinum neurotoxin complex.

Authors:  Tsutomu Matsui; Shenyan Gu; Kwok-Ho Lam; Lester G Carter; Andreas Rummel; Irimpan I Mathews; Rongsheng Jin
Journal:  J Mol Biol       Date:  2014-09-18       Impact factor: 5.469

9.  Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex.

Authors:  Kwangkook Lee; Xiaofen Zhong; Shenyan Gu; Anna Magdalena Kruel; Martin B Dorner; Kay Perry; Andreas Rummel; Min Dong; Rongsheng Jin
Journal:  Science       Date:  2014-06-20       Impact factor: 47.728

10.  The Structure and Classification of Botulinum Toxins.

Authors:  Min Dong; Pål Stenmark
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.